1.	Effect of Soy on Cognition and Hot Flashes in Men With Prostate Cancer Undergoing Testosterone Suppression Therapy Phase: Phase IV Type: Supportive care Status: Completed Age: 21 and over Sponsor: NCI, Other Protocol IDs: 04-08-09-04, NCT00245518
2.	Phase III Randomized Study of the Effect of a Diet Low in Fat and High in Soy, Fruits, Vegetables, Green Tea, Vitamin E, and Fiber on PSA Levels in Patients With Prostate Cancer (Summary Last Modified 04/2002). Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: Phase III Type: Prevention, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSKCC-98014, NCI-G98-1445, NCT00003367
3.	Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation Phase: Phase III Type: Supportive care Status: Closed Age: 21 and over Sponsor: NCI Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
4.	Vitamin E, Selenium, and Soy Protein in Preventing Cancer in Patients With High-Grade Prostate Neoplasia Phase: Phase III Type: Prevention Status: Completed Age: Not specified Sponsor: Other Protocol IDs: PRP1, CAN-NCIC-PRP1, CDR0000310096, NCT00064194
5.	Phase II Trial of Dietary Fatty Acids: Roles in Hormonally Mediated Cancers in Normal Premenopausal Women (Summary Last Modified 06/98) Phase: Phase II Type: Prevention Status: Closed Age: 18-35 Sponsor: NCI Protocol IDs: UMN-9509M10234, NCI-P97-0108
6.	Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease Phase: Phase II Type: Supportive care Status: Completed Age: Postmenopausal (20 and over) Sponsor: NCI, Other Protocol IDs: CDR0000069219, U10CA076001, CALGB-79805, NCI-P02-0206, NCT00031720
7.	Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000446088, P30CA022453, WSU-D-2325, NCT00243048
8.	Soy Protein and Breast Cancer Risk Reduction Phase: Phase II Type: Prevention Status: Closed Age: 30 to 40 Sponsor: Other Protocol IDs: 02-422, Army's HSRRB log no. A-10926, UTMB GCRC 533, DAMD17-01-1-0417, M01RR000073, 1UL1RR029876-01, NCT00204477
9.	Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Closed Age: Over 18 Sponsor: NCI, Other Protocol IDs: CDR0000466317, CCCWFU-98203, CCCWFU-BG03-332, NCT00345813
10.	The Effect of Soy Protein on Post- Breast Cancer Surgery Pain Phase: Phase II Type: Supportive care Status: Temporarily closed Age: 21 and over Sponsor: NCI, Other Protocol IDs: A02-M102-07A, 5R21CA125873-02, NCT01047774
11.	Phase I Randomized Study of Genistein for Prevention of Cancer in Patients With No History of Cancer or With Asymptomatic Early Prostate Cancer or Other Malignancy Phase: Phase I Type: Prevention, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-98-C-0099B
12.	Dietary Intervention Study of Low-Fat Diet, Fish Oil, and Soy Supplements in Breast Cancer Patients Phase: No phase specified Type: Treatment Status: Closed Age: 18 and over Sponsor: Other Protocol IDs: UCLA-HSPC-9508339, NCI-V96-0940
13.	Pilot Study of Soy-Based Meal Replacement (Almased®) as a Weight Loss Intervention in Patients With Estrogen Receptor/Progesterone Receptor-Negative Stage I-III Breast Cancer in Complete Remission. Note: The information about this trial has not been updated by the sponsor/principal investigator/lead organization. Cancer.gov cannot verify the accuracy of the information. Phase: No phase specified Type: Behavioral study, Educational/Counseling/Training, Supportive care Status: Closed Age: 21 and over Sponsor: NCI Protocol IDs: CCCWFU-98904, NCT00343434